Staging of lymph nodes with fdg dual-headed pet in patients with non-small-cell lung cancer

Nuclear Medicine Communications

Volumn 20, Issue 11, 1999, Pages 1001-1008

  Stokkel, Marcel P M ^a   Bakker, P F A ^a   Heine, R ^a   SchloSser N J J ^a   Lammers, J W J ^a   Van Rijk, P P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLUCOSE METABOLISM; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT; THORACOTOMY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032745806     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199911000-00004     Document Type: Article

References (31)

1. Armstrong P, Vincent JM. Staging non-small cell lung cancer. Clin Radiol 1993; 48: 1-10.
2. McLoud T, Bourgouin PM, Greenberg RW et al. Bronchogenic carcinoma: Analysis of staging the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
3. Armstrong P. Preoperative computed tomographic scanning for staging lung cancer. Thorax 1994; 49: 941-943.
4. Laissy JP, Gay-Depassier P, Soyer P et al. Enlarged mediastinal lymph nodes in bronchogenic carcinoma: Assessment with dynamic contrast-enhanced MR imaging. Radiology 1994; 191: 263-267.
5. Webb RW, Gatsonis C, Zerhouni EA et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the radiologic diagnostic oncology group. Radiology 1991: 178: 705-713.
6. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardiothomc Surg 1994; 8: 37-42.
7. Duhaylongsod FD, Lowe VJ, Patz EF, Vaughn AL, Coleman R, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995; 60: 1348-1352.
8. Stokkel MP, Terhaard CH, Mertens IJ, Hordijk GJ, Van Rijk PP. Fluorine-18-FDG detection of laryngeal cancer post-radiotherapy using dual head coincidence imaging. J Nucl Med 1998; 39: 1385-1387.
9. Stokkel MPM, Ten Broek FW, Van Rijk PP. Preoperative assessment of cervical lymph nodes in head and neck cancer with FDG using a dual head coincidence camera: A pilot study. Eur J Nucl Med 1999; 26: 499-503.
10. American Thoracic Society. Clinical staging of primary lung cancer. Am J Rev Respir Dis 1983; 127: 659-664.
11. Patz EF, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest 1995; 108: 1617-1621.
12. Bury Th, Paulus P, Dowlati A et al. Staging of the media-stinum: Value of positron emission tomography imaging in non-small cell lung cancer. Eur Resp J 1996; 9: 2560-2564.
13. Steinert HC, Hauser M, Allemann F et al. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
14. Bury Th, Dowlati A, Paulus P et al. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Resp J 1997; 10: 2529-2534.
15. Vansteenkiste JF, Stroobants SG, De Leyn PR et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-2149.
16. Vansteenkiste JF, Stroobants SG, De Leyn PR et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer. Chest 1997; 112: 1480-1486.
17. Sazon DAD, Santiago SM, Hoo GWS et al. Fluorodeoxyglu-cose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153: 417-421.
18. Chin R, Ward R, Keyes JW et al. Mediastinal staging in non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152: 2090-2096.
19. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer: Evaluation by [18F]FDG positron emission tomography (PET). Thorax 1997; 52: 438-441.
20. Weber W, Neverve J, Sklarek J et al. Mediastinal staging of lung cancer with F-18-FDG: Comparison of a dual head coincidence camera with a full ring PET scanner. J Nucl Med 1998; 39: 247P.
21. Grahek D, Montravers F, Kerrou K et al. Staging of lung cancer by [18FJ-FDG on a dual-headed gamma camera with coincidence detection (CDET). Eur J Nucl Med 1998; 25: 932.
22. Scott W, Schwabe JL, Gupta NC, Dewan NA, Reeb SD, Sugimoto JT (Members of the PET-Lung Tumor Study Group). Positron emission tomography of lung tumors and mediastinal lymph nodes using [F18]fluorodeoxyglucose. Ann Thorac Surg 1994; 58: 698-703.
23. Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110: 130-140.
24. Kubota K, Matsuzawa T, Fujiwara T et al. Differential diag-nosis of lung tumor with positron emission tomography: A prospective study. J Nucl Med 1990; 31: 1927-1933.
25. Hamberg L, Hunter GJ, Alpert NM et al. The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-1312.
26. Shreve PD, Steventon RS, Deters EC, Kison PV, Gross MD, Wahl RL. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-437.
27. Landoni C, Gianolli L, Lucignani G et al. Comparison of dual-head coincidence imaging PET (DHCI-PET) vs conventional ring PET (RING-PET) in tumor patients. Eur J Nucl Med 1998; 25: 931.
28. Zimny M, Kaiser U, Cremerius P et al. Gamma camera coincidence system versus full ring PET-scanner: First results in oncologic patients. Eur J Nucl Med 1998; 25: 931.
29. Stokkel MPM, van Isselt JW, Hoekstra A, van Rijk PP. Lesions of 4 mm and 5 mm detected with 18F-FDG using a dual head coincidence camera. Eur J Nucl Med 1998; 25: 1032.
30. Stokkel M, Stevens H, Taphoorn M, Van Rijk P. Differentiation between recurrent brain tumour and post-radiation necrosis: The value of 201T1 SPET versus 18F-FDG using a dual-headed coincidence camera-a pilot study. Nucl Med Commun 1999; 20: 411-417.
31. Ahuja V, Coleman RE, Herndon J, Patz EF. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer 1998; 83: 918-924.